Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States.
暂无分享,去创建一个
M. Lipsitch | W. Schaffner | R. Link-Gelles | R. Lynfield | L. Harrison | M. Farley | J. Jorgensen | A. Thomas | M. Moore | S. Zansky | B. Juni | S. Petit | P. D. Kirley | D. Jackson | D. Aragon | Megin Nicols
[1] M. Lipsitch,et al. Niche and Neutral Effects of Acquired Immunity Permit Coexistence of Pneumococcal Serotypes , 2012, Science.
[2] W. Schaffner,et al. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. , 2012, The Journal of infectious diseases.
[3] M. Lipsitch,et al. Serotype replacement in disease after pneumococcal vaccination , 2011, The Lancet.
[4] M. Haber,et al. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] W. Schaffner,et al. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] Matthew R Moore,et al. A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination. , 2010, Vaccine.
[7] R. Lynfield,et al. Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. , 2010, The Journal of infectious diseases.
[8] W. Schaffner,et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. , 2010, The Journal of infectious diseases.
[9] Marc Lipsitch,et al. What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae? , 2009, Journal of The Royal Society Interface.
[10] D. Greenberg,et al. The Association Between Antibiotic Use in the Community and Nasopharyngeal Carriage of Antibiotic-Resistant Streptococcus pneumoniae in Bedouin Children , 2008, The Pediatric infectious disease journal.
[11] W. Schaffner,et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. , 2008, The Journal of infectious diseases.
[12] A. Shefer,et al. Trends in Acute Otitis Media-Related Health Care Utilization by Privately Insured Young Children in the United States, 1997–2004 , 2008, Pediatrics.
[13] Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. , 2008, MMWR. Morbidity and mortality weekly report.
[14] Clinical,et al. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement , 2008 .
[15] P. Paakkari,et al. Macrolide and Azithromycin Use Are Linked to Increased Macrolide Resistance in Streptococcus pneumoniae , 2006, Antimicrobial Agents and Chemotherapy.
[16] W. Schaffner,et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. , 2006, The New England journal of medicine.
[17] F. Baquero,et al. Geographical and Ecological Analysis of Resistance, Coresistance, and Coupled Resistance to Antimicrobials in Respiratory Pathogenic Bacteria in Spain , 2005, Antimicrobial Agents and Chemotherapy.
[18] M. Jacobs,et al. Macrolide resistance: an increasing concern for treatment failure in children , 2003, The Pediatric infectious disease journal.
[19] Marc Lipsitch,et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States , 2003, Nature Medicine.
[20] E. Lewis,et al. Impact of the pneumococcal conjugate vaccine on otitis media , 2003, The Pediatric infectious disease journal.
[21] F. Baquero,et al. Importance of Local Variations in Antibiotic Consumption and Geographical Differences of Erythromycin and Penicillin Resistance in Streptococcus pneumoniae , 2002, Journal of Clinical Microbiology.
[22] Susan R. Johnson,et al. Macrolide Resistance among Invasive Streptococcus Pneumoniae Isolates , 2022 .
[23] R. Dagan,et al. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees , 2001, The Pediatric infectious disease journal.
[24] M. Lipsitch,et al. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] L. Harrison,et al. Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.
[26] M. Cetron,et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. , 2000, The New England journal of medicine.
[27] G. Doern,et al. Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae. , 2000, Emerging infectious diseases.
[28] Paterick Bd,et al. Geographic Variation in Penicillin Resistance in Streptococcus pneumoniae: Selected Sites, United States, 1997. , 2000, Annals of emergency medicine.
[29] Paterick Bd,et al. Geographic variation in penicillin resistance in Streptococcus pneumoniae--selected sites, United States, 1997. , 1999, MMWR. Morbidity and mortality weekly report.